BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27613657)

  • 21. Early gastric mixed neuroendocrine-non-neuroendocrine neoplasm with early poor prognosis after endoscopic submucosal dissection: A case report.
    Tomita Y; Seki H; Matsuzono E; Kobayashi Y; Sogabe S; Sugai N; Fujita J; Suzuki A
    DEN Open; 2022 Apr; 2(1):e10. PubMed ID: 35310728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
    Pellat A; Cottereau AS; Terris B; Coriat R
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms.
    Zhang Q; Wang H; Xie Y; Huang S; Chen K; Ye B; Yang Y; Sun J; He H; Liu F; Shen Z; Chen W; Shen K; Ji Y; Sun Y
    Endocr Connect; 2021 Aug; 10(8):947-954. PubMed ID: 34289448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms.
    Han D; Li YL; Zhou ZW; Yin F; Chen J; Liu F; Shi YF; Wang W; Zhang Y; Yu XJ; Xu JM; Yang RX; Tian C; Luo J; Tan HY
    World J Gastroenterol; 2021 Jun; 27(21):2895-2909. PubMed ID: 34135560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric mixed adenoma-neuroendocrine tumor: A case report.
    Kohno S; Aoki H; Kato M; Ogawa M; Yoshida K
    World J Clin Cases; 2020 Nov; 8(22):5744-5750. PubMed ID: 33344569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    Ma F; Wang B; Xue L; Kang W; Li Y; Li W; Liu H; Ma S; Tian Y
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2135-2142. PubMed ID: 32306127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
    Karakaş Y; Laçin Ş; Kurtulan O; Esin E; Sunar V; Sökmensüer C; Kılıçkap S; Yalçin Ş
    Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of various growth factors in patients with different gastric neoplasms.
    Kędzierska L; Madej-Michniewicz A; Marczuk N; Dołęgowska B; Starzyńska T; Błogowski W
    Am J Transl Res; 2020; 12(1):118-129. PubMed ID: 32051741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis.
    Frizziero M; Chakrabarty B; Nagy B; Lamarca A; Hubner RA; Valle JW; McNamara MG
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group.
    Armstrong EA; Beal EW; Lopez-Aguiar AG; Poultsides G; Cannon JG; Rocha F; Crown A; Barrett J; Ronnkleiv-Kelly S; Fields RC; Krasnick BA; Idrees K; Smith PM; Nathan H; Beems MV; Maithel SK; Schmidt CR; Pawlik TM; Dillhoff M
    Am Surg; 2019 Dec; 85(12):1334-1340. PubMed ID: 31908214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors.
    Yan S; Liu T; Li Y; Zhu Y; Jiang J; Jiang L; Zhao H
    Ann Transl Med; 2019 Oct; 7(20):545. PubMed ID: 31807527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Gastrointestinal Neuroendocrine Tumors.
    Wang R; Zheng-Pywell R; Chen HA; Bibb JA; Chen H; Rose JB
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419884058. PubMed ID: 31695546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
    Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
    World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.
    Felder S; Jann H; Arsenic R; Denecke T; Prasad V; Knappe-Drzikova B; Maasberg S; Wiedenmann B; Pavel M; Pascher A; Pape UF
    Endocr Relat Cancer; 2019 Sep; 26(9):751-763. PubMed ID: 31272081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hepatic sclerosing hemangioma emerged in the postoperative course of multiple gastric carcinoid tumors masquerading as metachronous liver metastasis.
    Koyama R; Minagawa N; Maeda Y; Shinohara T; Hamada T
    Int J Surg Case Rep; 2019; 58():1-5. PubMed ID: 30986640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study.
    Tian FX; Cai YQ; Zhuang LP; Chen MF; Xiu ZB; Zhang Y; Liu H; Liu ZH; Liu GP; Zeng C; Lin FL; Liu J; Huang ST; Zhang LZ; Lin HY
    Cancer Med; 2018 Nov; 7(11):5359-5369. PubMed ID: 30311450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation.
    Farooq F; Zarrabi K; Sweeney K; Kim J; Bandovic J; Patel C; Choi M
    J Gastric Cancer; 2018 Jun; 18(2):200-207. PubMed ID: 29984070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous Triple Gastric Cancer Incorporating Mixed Adenocarcinoma and Neuroendocrine Tumor Completely Resected with Endoscopic Submucosal Dissection.
    Kubo K; Kimura N; Mabe K; Nishimura Y; Kato M
    Intern Med; 2018 Oct; 57(20):2951-2955. PubMed ID: 29780136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph Node Metastasis of Mixed Adenoneuroendocrine Carcinoma after Curative Resection Using the Expanded Criteria for Early Gastric Cancer.
    Ochiai T; Ominami M; Nagami Y; Fukunaga S; Toyokawa T; Yamagami H; Tanigawa T; Watanabe T; Ohira M; Ohsawa M; Fujiwara Y
    Intern Med; 2018 Oct; 57(19):2837-2842. PubMed ID: 29780112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component.
    Pham QD; Mori I; Osamura RY
    Case Rep Pathol; 2017; 2017():9871687. PubMed ID: 28626594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.